NCT00365118

Completed

Treatment of Naevus Flammeus Using Intense Pulsed Light and ...

Bispebjerg Hospital Source

Compare

Other study identifiers

Sponsor study identifier

KF-01-278867

Study Type

interventional

Reported enrollment (type unavailable)

N/A

Locations

1 country

Sites

1

Timeline

Study Start

November 2005

Date type not reported

This date has not been verified as actual or estimated.

Primary Completion

December 2007

Actual (reported)

Study Completion

December 2007

Actual (reported)

Brief Summary

The purpose of the trial is to compare efficacy and adverse effects of pulsed dye laser and intense pulsed light in patients with port wine stains.

Registry Overview

Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.

Recruitment status: completed
Reported enrollment (type unavailable): Not reported
Study completion date: December 2007
Actual (reported)
Listed locations: 1 countries · 1 sites

Trial Relationships

Click on a node to explore related trials.

Some registry-reported names shown below are not yet linked in this graph.

Study Timeline

Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.

Study Start
November 2005
Date type not reported
This date has not been verified as actual or estimated.
First Submitted
August 15, 2006
Actual (reported)
First Posted
August 17, 2006
Actual (reported)
Primary Completion
December 2007
Actual (reported)
Study Completion
December 2007
Actual (reported)

Last Updated: June 3, 2008
Status Verified: June 2008
Last Update Submitted: June 2, 2008

Conditions

Port-Wine Stain

Keywords

Port wine stainsnaevus flammeus

Interventions

Pulsed dye laser (Candela), Intense pulsed light (Palomar)Device

Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.

Eligibility Criteria

Age2 Years+

Sexall

Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

Patients with previously untreated and previously laser-treated naevus flammeus. Naevus flammeus measuring at least 5 x 7 cm within a single anatomical area. For example, the face corresponding to dermatomes V1, V2 and V3, back, abdomen, arms and legs.Patients aged two or above.Patients with skin types I-III.

You may not qualify if:

Sponsors & Collaborators

Bispebjerg Hospital
Otherlead

Study Sites (1)

Bispebjerg Hospital

Copenhagen, Copenhagen Nv, 2400, Denmark

MeSH Terms

Conditions

Port-Wine StainHemangioma, Capillary

Interventions

Lasers, Dye

Condition Hierarchy (Ancestors)

Skin AbnormalitiesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesSkin DiseasesSkin and Connective Tissue DiseasesHemangiomaNeoplasms, Vascular TissueNeoplasms by Histologic TypeNeoplasms

Intervention Hierarchy (Ancestors)

Study Officials

Merete Hædersdal, MD, PhD, DrMedSci
Bispebjerg Hospital
PRINCIPAL INVESTIGATOR

Study Design

Study Type: interventional
Phase: not applicable
Allocation: RANDOMIZED
Masking: SINGLE
Purpose: TREATMENT
Intervention Model: SINGLE GROUP
Sponsor Type: OTHER

Study Record Dates

First Submitted

August 15, 2006

First Posted

August 17, 2006

Study Start

November 2005

Date type not reported

This date has not been verified as actual or estimated.

Primary Completion

December 2007

Actual (reported)

NCT02214706

Treatment of Port Wine Stains Using Pulsed Dye Laser, Erbium Yag Laser and Topical Sirolimus

Not ApplicableTerminated

NCT01775722

Combined Bipolar Radiofrequency&Pulsed Dye Laser Treatment

Not ApplicableCompleted

NCT00782483

Personalized Interactive Laser Therapy of Port Wine Stain

Not ApplicableTerminated

NCT01101360

Port Wine Stains Treatment Matrix RF Study

Not ApplicableCompleted

NCT04536740

Effect of Pulsed Dye Laser on Photodynamic Therapy of Port-Wine Stains

Not ApplicableUnknown

NCT07183644

Maximizing Laser Therapy Success for Port-Wine Birthmarks in Pediatric Patients

Not ApplicableRecruiting

Patients below two years of age.

Pregnant or breastfeeding patients.

Patients with known increased sensitivity to visible light.

Patients with a tendency to produce hypertrophic scars or celoids.

Patients with skin types IV, V and VI.

Patients who are clearly pigmented following recent exposure to the sun or a solarium.

Patients treated with Roaccutane during the last six months.

Patients who are not considered able to follow the treatment protocol (e.g. severely alcoholic patients, dementia patients, mentally ill patients, etc.).

Contact the study team to confirm eligibility.

Lasers

Optical Devices

Equipment and Supplies

Radiation Equipment and Supplies

Study Completion

December 2007

Actual (reported)

Last Updated

June 3, 2008

Record last verified: 2008-06

Source record

Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.

Source: ClinicalTrials.gov.

JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.

Registry identifier: NCT00365118
Data provider: ClinicalTrials.gov
Source updated: 2008-06-03
Normalization version: ctgov-legacy-1

Open registry record

Source retrieved: 2026-10-25 22:31:55 UTC

Locations

DK(1)

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

First Submitted

First Posted

Primary Completion

Study Completion

Conditions

Keywords

Interventions

Eligibility Criteria

You may qualify if:

You may not qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Interventions

Condition Hierarchy (Ancestors)

Intervention Hierarchy (Ancestors)

Study Officials

Study Design

Study Record Dates

Source record

Locations